You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Radiation Protection Cancer Therapy with an SOD Mimetic
SBC: AEOLUS PHARMACEUTICALS, INC. Topic: N/ADESCRIPTION (provided by applicant): Phase I. In the treatment of cancer, radiation therapy has been limited by the tolerance of the surrounding normal tissues, such as lung or mucosa. Until now, there have been no compounds available that protect the nor
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Device for Rapid Gene Detection of Multiple Bio-Agents
SBC: ALDERON BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): Despite our progress in combating infectious diseases during the last century, many of those diseases still represent major threats. Moreover, we now have the technical capability to render those diseases even more dan
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
One-Step Rapid Screening for Childhood Lead Poisoning
SBC: ALDERON BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): The CDC states that lead poisoning is the number one environmental health problem, affecting children in the US because it affects one of every six at-risk children and it is acknowledged to be a source of cognitive an
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Super-Precision Capacitance Bridge
SBC: Andeen-Hagerling, Inc. Topic: N/ANIST desires to develop a standard of pressure in the range 0.3 MPa to 10 MPa based on measurements of the dielectric constants of gaseous helium and argon. This requires capacitance measurements having a better linearity than can be made with any currently available product. It is proposed that the design of the currently most precise commercial capacitance bridge be modified to improve its linea ...
SBIR Phase II 2004 Department of CommerceNational Institute of Standards and Technology -
Refanalin for Liver Transplantation
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Orthotopic liver transplantation is the most effective treatment for patients with end-stage liver disease. Ischemia-reperfusion injury associated with the retrieval, storage and transplantation of livers is a major
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Hepatic Growth Factor Mimetic for Liver Fibrosis
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Hepatic fibrosis, a disease affecting tens of millions of patients worldwide, is the liver scarring response to chronic injury from viral hepatitis B or C, excessive alcohol use, iron overload or extrahepatic obstr
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Anti-Selectin Blocker for Liver Ischemic Injury
SBC: BIOMEDICA MANAGEMENT CORP. Topic: N/ADESCRIPTION (provided by applicant): Our objective is to develop a new treatment that will prevent or decrease the tissue damage caused by neutrophil infiltration after ischemia/reperfusion (I/R), which occurs as the result of stroke, coronary isc
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
ASSAY TO DETECT ACUTE ACTIVE LYME DISEASE
SBC: Bioscience Development Inc Topic: N/ALyme disease (LD) cases due to Borrelia burgdorferi (Bb) are increasing. Assays to detect active infection are urgently needed. The primary objective of this proposal is to develop an assay for active infection based upon Bb specific immune complexes (IC)
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Pretest Probability Assessment for Pulmonary Embolism
SBC: BREATHQUANT MEDICAL SYSTEMS, INC. Topic: N/ADESCRIPTION (provided by applicant): Pretest probability assessment (PTP) plays a pivotal role in the evaluation of pulmonary embolism (PE) in the emergency department (ED) and accurate PTP assessment can modify defensive test-ordering behavior by physicians. However, current methods of PTP assessment produce broad categories of risk that tend to over fit individual patients and seldom obviate tes ...
STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Behavioral Intervention to Prevent Falls in Older Adults
SBC: BROOKSIDE RESEARCH & DEVELOPMENT COMPANY Topic: N/ADESCRIPTION (provided by applicant): Falls are the leading cause of injury deaths, severe nonfatal injuries, and hospital admissions in older adults. In 1994 the cost of seniors' fall injuries was 20.2 billion, these costs are significant to individuals a
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health